综述解读

2 型糖尿病与成人肌少症的关联:一项荟萃分析

来源:Diabetes research and clinical practice · PMID 42956840 · DOI 10.1016/j.diabres.2026.113619 · 来源:IMA 知识库《文献层·文献监控卡片》2026-11-01 期 · 摘要级(file_id dlMXdlgtPZzo,实际下载核验) · 摘要级,未获取付费墙全文

时间标签:数据日期 2026-11-01 · 生成时间 2026-11-01 05:30(Asia/Shanghai)| 检索窗口 PubMed edat 2026/10/31–2026/11/01 | 情报发生日期 2026-11-01

证据级别:摘要级。本条依据 PubMed 结构化摘要与元数据撰写,付费墙全文未获取、未逐节核验,本站未做任何数值推算补全。

研究问题

We aimed to quantify associations between sarcopenia and T2DM, prediabetes, and diabetes-related complications in adults.;Adults with T2DM have moderately higher odds of sarcopenia than non-diabetic adults, though observational design and heterogeneity limit causal claims.

方法

Associations were consistent across study designs, regions, and muscle-mass assessment methods, with no single study driving results or evidence of funnel-plot asymmetry.;Adults with T2DM have moderately higher odds of sarcopenia than non-diabetic adults, though observational design and heterogeneity limit causal claims.

核心结论

T2DM was associated with higher odds of sarcopenia (pooled OR 1.61, 95 % CI 1.26-2.06), despite substantial heterogeneity and a wide prediction interval.;Associations were consistent across study designs, regions, and muscle-mass assessment methods, with no single study driving results or evidence of funnel-plot asymmetry.;Prediabetes was not significantly associated with sarcopenia (OR 1.16, 95 % CI 0.63-2.15).;Among complications, diabetic foot disease was associated with higher sarcopenia odds, whereas estimates for retinopathy, nephropathy, and neuropathy were imprecise and non-significant.;Adults with T2DM have moderately higher odds of sarcopenia than non-diabetic adults, though observational design and heterogeneity limit causal claims.

局限

Two reviewers independently screened studies, extracted data, and evaluated bias.;T2DM was associated with higher odds of sarcopenia (pooled OR 1.61, 95 % CI 1.26-2.06), despite substantial heterogeneity and a wide prediction interval.;Adults with T2DM have moderately higher odds of sarcopenia than non-diabetic adults, though observational design and heterogeneity limit causal claims.

对本项目的价值

综述级证据,用于快速对齐领域共识与空白:功能结局(衰弱 / 肌少症)是临床转化最可及的终点,适合作为一期终点候选。 | 价值分 1.3/5(★☆☆☆☆)

全文来源

未取到全文 → 本卡为摘要级解读,未核验全文

原文题录

  • 英文标题:Association of type 2 diabetes mellitus with sarcopenia in adults: A meta-analysis.
  • 期刊与标识:Diabetes research and clinical practice · PMID 42956840 · DOI 10.1016/j.diabres.2026.113619

C 级证据分级:C 级(预印本 / 观点评论,非原始研究)

本文属观点/评论类文献,不是原始研究。其论点依赖于作者对既有证据的梳理与判断,不构成新的实验证据。本站标注 C 级即为此意——阅读时请把它当作「领域内的思考框架」,而非「研究发现」。

关于本文的文献来源:本站依据 IMA 知识库「五刊监控·深度文献卡片」(SOP §4.2 摘要级)撰写,依据期刊公开摘要与 PubMed 元数据;付费墙全文未获取之处已标注「待补全文」,未做任何数值推算补全。